DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,538,011 | +6.3% | 139,210 | +2.9% | 3.62% | +13.7% |
| Q2 2023 | $32,477,479 | -1.5% | 135,323 | +3.5% | 3.19% | -8.8% |
| Q1 2023 | $32,959,671 | -5.2% | 130,772 | -0.1% | 3.49% | -9.6% |
| Q4 2022 | $34,752,872 | +5.3% | 130,935 | +2.5% | 3.86% | -0.3% |
| Q3 2022 | $32,995,000 | -0.5% | 127,742 | -2.4% | 3.88% | +2.7% |
| Q2 2022 | $33,169,000 | -15.0% | 130,835 | -1.7% | 3.78% | +0.7% |
| Q1 2022 | $39,022,000 | -7.9% | 133,030 | +3.3% | 3.75% | -2.8% |
| Q4 2021 | $42,356,000 | +6.5% | 128,737 | -1.4% | 3.86% | -3.9% |
| Q3 2021 | $39,754,000 | +5.7% | 130,579 | -6.8% | 4.02% | +5.9% |
| Q2 2021 | $37,596,000 | +20.6% | 140,094 | +1.2% | 3.79% | +11.2% |
| Q1 2021 | $31,169,000 | +3.1% | 138,481 | +1.7% | 3.41% | -1.5% |
| Q4 2020 | $30,241,000 | +1.1% | 136,134 | -2.0% | 3.46% | -11.0% |
| Q3 2020 | $29,913,000 | +8.0% | 138,916 | -11.3% | 3.89% | +1.0% |
| Q2 2020 | $27,688,000 | +25.1% | 156,578 | -2.0% | 3.85% | +2.9% |
| Q1 2020 | $22,124,000 | -9.6% | 159,844 | +0.2% | 3.74% | +6.2% |
| Q4 2019 | $24,477,000 | +6.2% | 159,478 | -0.0% | 3.52% | -2.5% |
| Q3 2019 | $23,038,000 | -0.4% | 159,510 | -1.5% | 3.61% | +1.0% |
| Q2 2019 | $23,135,000 | +4.7% | 161,874 | -3.3% | 3.57% | +0.3% |
| Q1 2019 | $22,106,000 | +38.1% | 167,447 | +7.9% | 3.56% | +9.0% |
| Q4 2018 | $16,008,000 | -11.8% | 155,236 | -7.0% | 3.27% | +6.9% |
| Q3 2018 | $18,144,000 | +13.1% | 166,979 | +2.7% | 3.06% | +3.2% |
| Q2 2018 | $16,044,000 | +2.6% | 162,582 | +1.8% | 2.96% | -0.5% |
| Q1 2018 | $15,638,000 | +8.8% | 159,714 | +3.1% | 2.98% | +8.6% |
| Q4 2017 | $14,378,000 | +12.3% | 154,901 | +3.8% | 2.74% | +2.5% |
| Q3 2017 | $12,804,000 | +22.9% | 149,266 | +20.9% | 2.67% | +15.4% |
| Q2 2017 | $10,418,000 | +2.6% | 123,454 | +4.0% | 2.32% | -1.0% |
| Q1 2017 | $10,157,000 | +14.8% | 118,752 | +4.5% | 2.34% | +4.8% |
| Q4 2016 | $8,847,000 | +14.6% | 113,651 | +15.4% | 2.23% | +15.5% |
| Q3 2016 | $7,718,000 | +26.2% | 98,461 | +62.6% | 1.93% | +21.1% |
| Q2 2016 | $6,116,000 | +93.7% | 60,559 | +81.9% | 1.60% | +87.2% |
| Q1 2016 | $3,158,000 | +168.8% | 33,296 | +163.3% | 0.85% | +174.8% |
| Q4 2015 | $1,175,000 | +199.7% | 12,646 | +174.9% | 0.31% | +187.0% |
| Q3 2015 | $392,000 | +4.0% | 4,600 | +4.5% | 0.11% | +11.3% |
| Q2 2015 | $377,000 | +0.8% | 4,400 | 0.0% | 0.10% | -1.0% |
| Q1 2015 | $374,000 | -0.8% | 4,400 | 0.0% | 0.10% | -13.3% |
| Q4 2014 | $377,000 | +12.9% | 4,400 | 0.0% | 0.11% | +8.7% |
| Q3 2014 | $334,000 | -3.5% | 4,400 | 0.0% | 0.10% | -1.0% |
| Q2 2014 | $346,000 | +4.8% | 4,400 | 0.0% | 0.10% | +1.0% |
| Q1 2014 | $330,000 | -2.9% | 4,400 | 0.0% | 0.10% | -4.6% |
| Q4 2013 | $340,000 | +11.5% | 4,400 | 0.0% | 0.11% | -4.4% |
| Q3 2013 | $305,000 | +9.3% | 4,400 | 0.0% | 0.11% | -4.2% |
| Q2 2013 | $279,000 | +2.2% | 4,400 | 0.0% | 0.12% | +2.6% |
| Q1 2013 | $273,000 | – | 4,400 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |